The department is also identified as one of five centres of excellence for research on MDR-TB (multidrug resistant TB) in the ...

Stock analysts at Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for shares of Theratechnologies in a note issued to investors on Friday, October 11th. Cantor Fitzgerald ...

The Lagos State Commissioner for Health, Prof Akin Abayomi, has said multidrug-resistant organisms are a major biosecurity ...

New data to be shared on GSK’s RSV vaccine across different age groups of patients at increased risk • Efficacy data for gepotidacin in ...

Globally, the prevalence of multidrug-resistant tuberculosis (MDR-TB) has been increasing recently. This is a major public health concern, as MDR-TB is more difficult to treat and has poorer outcomes ...

今年8月23日，我们团队——中国科学院微生物研究所向华团队，在国际期刊《自然·通讯》（Nature Communications）杂志上发表了题为《工程化最小I型 CRISPR-Cas ...

Doctor Elizabeth Nyirazihaawe, the Supervisor of the TB and Leprosy Control Program at Masaka Regional Referral Hospital, ...

Omitting the 5-fluorouracil bolus from multidrug regimens could improve the tolerability of treatment without compromising efficacy in patients with advanced gastrointestinal cancers, a new study ...

Researchers develop single atom-engineered antibiotics using graphene and manganese ions, offering a new solution to tackle ...

This week, a phase 3 clinical trial showed aztreonam-avibactam might be treatment option for patients facing multidrug-resistant infections. Meanwhile, research shows that penicillin allergies in ...

A study of long-term care facilities found residents with penicillin allergies were 95% less likely to receive beta-lactam ...

Results from the REVISIT trial show aztreonam-avibactam had similar cure rates as meropenem in patients with serious ...